IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,603,600 | -0.0% | 145,582 | -9.6% | 0.01% | +11.1% |
| Q2 2023 | $6,605,748 | +11.9% | 160,998 | -2.5% | 0.01% | 0.0% |
| Q1 2023 | $5,903,533 | -6.9% | 165,180 | -1.6% | 0.01% | -10.0% |
| Q4 2022 | $6,340,639 | -13.6% | 167,875 | +1.2% | 0.01% | -16.7% |
| Q3 2022 | $7,339,000 | +17.0% | 165,925 | -2.1% | 0.01% | +20.0% |
| Q2 2022 | $6,272,000 | +0.6% | 169,414 | +0.6% | 0.01% | +25.0% |
| Q1 2022 | $6,236,000 | +11.4% | 168,362 | -8.5% | 0.01% | +14.3% |
| Q4 2021 | $5,599,000 | -26.1% | 184,004 | -18.6% | 0.01% | -30.0% |
| Q3 2021 | $7,580,000 | -22.0% | 225,991 | -7.3% | 0.01% | -16.7% |
| Q2 2021 | $9,722,000 | -11.8% | 243,722 | -0.6% | 0.01% | -20.0% |
| Q1 2021 | $11,019,000 | -19.7% | 245,083 | +1.0% | 0.02% | -21.1% |
| Q4 2020 | $13,717,000 | +21.3% | 242,615 | +1.8% | 0.02% | +5.6% |
| Q3 2020 | $11,304,000 | -21.3% | 238,239 | -2.2% | 0.02% | -28.0% |
| Q2 2020 | $14,363,000 | +36.8% | 243,599 | +9.7% | 0.02% | +8.7% |
| Q1 2020 | $10,503,000 | -23.7% | 222,147 | -2.5% | 0.02% | 0.0% |
| Q4 2019 | $13,766,000 | +8.3% | 227,869 | +7.4% | 0.02% | -8.0% |
| Q3 2019 | $12,716,000 | -5.7% | 212,247 | +1.2% | 0.02% | -7.4% |
| Q2 2019 | $13,483,000 | -15.9% | 209,791 | +6.2% | 0.03% | -18.2% |
| Q1 2019 | $16,040,000 | +50.8% | 197,609 | +0.4% | 0.03% | +37.5% |
| Q4 2018 | $10,639,000 | +7.3% | 196,801 | +2.4% | 0.02% | +26.3% |
| Q3 2018 | $9,912,000 | +23.7% | 192,172 | -0.0% | 0.02% | +11.8% |
| Q2 2018 | $8,011,000 | -4.0% | 192,240 | +1.6% | 0.02% | -5.6% |
| Q1 2018 | $8,341,000 | -15.3% | 189,217 | -3.4% | 0.02% | -10.0% |
| Q4 2017 | $9,851,000 | -2.3% | 195,850 | -1.5% | 0.02% | -9.1% |
| Q3 2017 | $10,085,000 | -9.9% | 198,913 | -9.6% | 0.02% | -8.3% |
| Q2 2017 | $11,197,000 | +16.5% | 220,108 | -8.0% | 0.02% | +26.3% |
| Q1 2017 | $9,613,000 | -19.7% | 239,139 | -4.4% | 0.02% | -20.8% |
| Q4 2016 | $11,964,000 | +27.1% | 250,139 | -2.6% | 0.02% | +26.3% |
| Q3 2016 | $9,411,000 | +58.6% | 256,839 | +0.8% | 0.02% | +46.2% |
| Q2 2016 | $5,933,000 | -42.4% | 254,739 | +0.1% | 0.01% | -40.9% |
| Q1 2016 | $10,302,000 | -25.0% | 254,373 | +14.7% | 0.02% | -33.3% |
| Q4 2015 | $13,738,000 | – | 221,826 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |